Education|
March 1987
The Role of an Ultra Short-acting Adrenergic Blocker (Esmolol) in Patients Undergoing Coronary Artery Bypass Surgery
LAWRENCE HARRISON, M.D.;
LAWRENCE HARRISON, M.D.
*Senior Resident in Anesthesia.
Search for other works by this author on:
FIONA E. RALLEY, M.B.Ch.B.;
FIONA E. RALLEY, M.B.Ch.B.
†Assistant Professor in Anesthesia.
Search for other works by this author on:
J. EARL WYNANDS, M.D.;
J. EARL WYNANDS, M.D.
‡Professor in Anesthesia and Surgery.
Search for other works by this author on:
G. ROSS ROBBINS, M.D.;
G. ROSS ROBBINS, M.D.
†Assistant Professor in Anesthesia.
Search for other works by this author on:
MAGDI SAMI, M.D.;
MAGDI SAMI, M.D.
§Assistant Professor in Cardiology.
Search for other works by this author on:
RUTH RIPLEY, R.N.;
RUTH RIPLEY, R.N.
¶Research Assistant in Cardiology.
Search for other works by this author on:
HEATHER A. FULLERTON
HEATHER A. FULLERTON
**Research Assistant in Anesthesia.
Search for other works by this author on:
Anesthesiology March 1987, Vol. 66, 413–418.
Citation
LAWRENCE HARRISON, FIONA E. RALLEY, J. EARL WYNANDS, G. ROSS ROBBINS, MAGDI SAMI, RUTH RIPLEY, HEATHER A. FULLERTON; The Role of an Ultra Short-acting Adrenergic Blocker (Esmolol) in Patients Undergoing Coronary Artery Bypass Surgery. Anesthesiology 1987; 66:413–418 doi: https://doi.org/10.1097/00000542-198703000-00029
Download citation file:
